{"@id":"https://bioecon.ru/technology/engineered-human-heart-tissue/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://cn.bioecon.ru/technology/engineered-human-heart-tissue/","json":"https://cn.bioecon.ru/api/v1/technology/engineered-human-heart-tissue/index.json"},"id":"engineered-human-heart-tissue","industries":["research-tools","equipment","biomanufacturing","pharma"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/research-tools/","https://bioecon.ru/industries/equipment/","https://bioecon.ru/industries/biomanufacturing/","https://bioecon.ru/industries/pharma/"],"suppliers":["https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/syncti-singapore/","https://bioecon.ru/companies/de-sangosse/","https://bioecon.ru/companies/aker-biomarine/","https://bioecon.ru/companies/orf-genetics/","https://bioecon.ru/companies/terragia-biofuel-inc/","https://bioecon.ru/companies/life3-biotech/","https://bioecon.ru/companies/hofseth-biocare/","https://bioecon.ru/companies/cellmeat/"]},"maturity":8,"name":"人源多能干细胞衍生三维工程化跳动心肌组织（EHT，心脏毒性与功能评价）","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"高纯度hiPSC定向分化成熟心室肌细胞"},{"n":2,"title":"双柔性硅胶微立柱间胶原水凝胶取向灌注"},{"n":3,"title":"自发同步搏动机械拉应力成熟与肌小节取向"},{"n":4,"title":"高速机器视觉图像识别毫牛级收缩做功解算"}],"summary":"将人诱导多能干细胞分化心肌细胞（hiPSC-CMs）与心脏成纤维细胞共混，灌注浇筑于双弹性硅胶微柱之间构建三维取向跳动心肌束，通过光学或磁力连续非接触测定心肌束收缩做功、搏动频率节律及QT间期延长导致的促心律失常致死性风险。","url":"/technology/engineered-human-heart-tissue/","verified":"2026-11-22"}